Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan CARLSBAD, Calif., July 8, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, and has applied... Read more
BURLINGAME, CA – June 25, 2020 – Halo Labs, a life science instrumentation company developing tools for biologics researchers, today announced it has launched its latest aggregate and particle identification system, called Aura™. Aura is the next generation of the Horizon®, Halo Labs’ popular Backgrounded Membrane Imaging (BMI) platform. With as little as 5 µL and a linear range... Read more
Reliable, easy-to-use cryo-EM workflow solution quadruples throughput for pharma labs HILLSBORO, Ore., June 16, 2020 /PRNewswire/ — To help pharmaceutical companies obtain faster results in their drug discovery process and reduce the cost of bringing new drugs to market, Thermo Fisher Scientific has released the Thermo Scientific iSPA Workflow, the first commercially available single particle analysis (SPA) workflow... Read more
Basel, 13 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the phase III VIALE-A study, evaluating Venclexta®/Venclyxto® (venetoclax) in combination with azacitidine in people with previously untreated acute myeloid leukaemia (AML) who were ineligible for intensive induction chemotherapy. VIALE-A results were featured in the 25th European Hematology Association Virtual... Read more
Agreement calls for identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new turnkey, next-generation sequencing solution Read more
Basel, 28 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA) to evaluate the safety and efficacy of Actemra/RoActemra plus the investigational antiviral remdesivir, versus placebo plus remdesivir in hospitalised patients with severe COVID-19 pneumonia, in collaboration with Gilead Sciences, Inc. Read more
Thermo Fisher Scientific and CSL Enter Strategic Partnership to Provide Best-in-Class Pharma Services WALTHAM, Mass. and KING OF PRUSSIA, Penn., May 27, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and global biotechnology company, CSL Limited (ASX:CSL;USOTC:CSLLY) today announced they have entered into a strategic partnership to help meet... Read more
Basel, 27 May 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from the phase III Archway study, evaluating Port Delivery System with ranibizumab (PDS) in people living with neovascular or “wet” age-related macular degeneration (nAMD). PDS is a permanent refillable eye implant, approximately the size of a grain of rice,... Read more
Home Corporate Guide Message from the president Corporate Data Corporate History Corporate Executives Directions to Takara Bio Sustainability Initiatives Business Outline News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline News Release Investor Relstions Japanese... Read more